PDT Partners’s Vaxart VXRT Stock Holding History

PDT Partners’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,273	Closed	-$31K	–	1437
2014 Q4	$31K	Hold	1,273	–	–	﹤0.01%	603
2014 Q3	$35K	Hold	1,273	–	–	﹤0.01%	1258
2014 Q2	$40K	Buy	+1,273	New	+$53.2K	﹤0.01%	1380

Other funds holding VXRT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

PDT Partners's VXRT Position: Q1 2015 in Review

PDT Partners sold out of Vaxart (VXRT) in Q1 2015, closing a stake of 1,273 shares — an estimated $31K sold.

PDT Partners first reported a position in VXRT in Q2 2014 and held it in 3 quarters. The position peaked at $40K in Q2 2014. 49 funds tracked by Wall St. Rank hold VXRT as of Q1 2015.

PDT Partners reported no remaining Vaxart position as of Q1 2015 after selling out during the quarter.
PDT Partners sold 1,273 Vaxart shares in Q1 2015, an estimated $31K.
PDT Partners first reported a position in Vaxart in Q2 2014 and held it in 3 quarters.
PDT Partners's Vaxart position peaked at $40K in Q2 2014.
49 funds tracked by Wall St. Rank held Vaxart as of Q1 2015.

Based on PDT Partners's 13F filing for Q1 2015, filed 15 May 2015.